ReviewClinical and translational science2022

Changing the drug development and therapeutic paradigm with biologic drug combinations and bispecifics: How to choose between these two approaches?

Songmao Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.